RESEARCH GROUPS

Cardiovascular Diseases

Overview

Team

Publications

Patents

Dissemination

129

Number of publications

72.87
%

% Q1

37.21
%

% D1

48.84
%

% Leadership

25.40
%

% Female Leadership

3.41

CROWN (2021-2025)

24.59
%

HCP10% (2021-2025)

49.61
%

% Open access

45.74
%

% International Collaboration

34

Highly cited papers / HCP 1% (2021-2025)

19

Publications in high-IF journals with high Altmetric scores

38

Number of Ongoing Projectes (total)

5

International ongoing projects

10

Number of New projects (total)

2

International new projects

33

Number of Active clinical Trials

8

Number of New Clinical Trials

5

Number of Theses

We are appointed in leadership positions in the European Society of Cardiology. Since 2023, we are vice-chair of a new European COST action including >40 countries (EU-METAHEART CA22169) with the common interest of deciphering the metabolic alterations in heart failure from a multidisciplinary perspective. In general, we obtained budget for 9 research projects in competitive public calls (1 of them international). In addition, during 2025 we underwent 3 doctoral dissertations and we started 19 clinical trials. Finally, 3 patents were presented during 2025.

CORE/MISSIONS

  • Aging
  • AI, Data, Imaging & Digital Health
  • Environmental & Public Health

PROGRAMS

Group Leader

Ignacio Ferreira González

Principal Investigator (PI)

José Antonio Barrabés Riu, Jordi Bañeras, Neus Bellera, Begoña Benito Villabriga, Laura Dos Subirá, Bruno García del Blanco, Javier Inserte Igual, Nuria Rivas Gandara, José F Rodríguez Palomares, Antonio Rodríguez Sinovas, Marisol Ruiz Meana, Antonia Sambola Ayala, Gisela Teixidó, Andrea Guala, Antonia Pijuan Domènech, Farina Guillermo Romero, Laura Galián Gay

Researchers

Jordi Lozano, Raquel Adeliño, Eduard Ródenas, Irene Buera, Rubén Fernández Galera, Blanca Gordon, Gerard Martí Aguasca, Laia Milà Pascual, Berta Miranda Barrio, Gerard Oristrell Santamaria, Imanol Otaegui Irurueta, Alba Santos Ortega, Bernat Serra Creus, Vicenç Serra García, Filipa Valente, Pau Rello Sabaté, Toni Soriano, Yasím Belahnech Pujol, Aleix Olivella, Javier Cantalapiedra, Maria Vidal, M. José Azpiroz, Víctor González Fernández, Pablo Jordán, Ruper Oliveró

PhD Students

Jordi Pérez Rodón, María Nazarena Pizzi, David Aluja González, Mireia Andrés, Lidia Dux Santoy, Laia Yañez, Aitor Uribarri, Ana Méndez, Alvaro Calabuig, Marta Consegal, Jaume Francisco, Javier Limeres, Simonas Valiuska, Augusto Sao, Nuria Vallejo, Sara Delgado, Guillem Casas Masnou, Freddy Ganse, Laura Rubio, Mireia Bragulat, Juan Garrido, Marco Tomassino

Lab Technicians

Ángeles Rojas López

Ganse FG, Ernst LM, Rodríguez C, Ruiz-Meana M, Inserte J, Martínez-González J, Briones AM, García-Redondo AB, Consegal M, Miró-Casas E, Yáñez-Bisbe L, Pomposo A, Prades-Martínez M, Ferreira-González I, Puntes V, Benito B, Rodríguez-Sinovas A
Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles.
Part Fibre Toxicol. 2025 Dec 25;22(1):36
DOI: 10.1186/s12989-025-00649-2.
IF: 8.2

Lozano-Torres J, Ródenas-Alesina E, Francisco-Pascual J, Escalona R, Azpiroz MJ, González-Fernández V, Tomasino M, Soriano-Colomé T, Olivella A, Méndez Fernández AB, Moradi Kolbolandi M, Santos A, Adeliño R, Rodríguez-Palomares J, Sao-Avilés A, Urio-Garmendia G, Rivas-Gándara N, Belahnech Y, Ferreira-González I
Left ventricular dysfunction after pacemaker implantation: Who could benefit from upfront conduction system pacing?
Heart Rhythm. 2025 Oct 31:S1547-5271(25)03032-2.
DOI: 10.1016/j.hrthm.2025.10.051
IF: 5.8

Guala A, Cilla M, Teixido-Tura G, Martínez MA, Dux-Santoy Hurtado L, Galian-Gay L, Garrido-Oliver J, Latorre A, Servato ML, Majul H, Hernandez-Pineda AH, Granato C, Ferreira-González I, Evangelista A, Peña E, Rodriguez-Palomares J
Comparative Analysis of Aortic Stiffness: Magnetic Resonance Validation Against Mechanical Testing in Ex Vivo Aortic Specimens.
JACC Cardiovasc Imaging. 2025 Dec;18(12):1396-1398.
DOI: 10.1016/j.jcmg.2025.06.015
IF: 15.2

Alonso Tello A, Sambola A, Valente F, Sao A, Ródenas-Alesina E, Rello P, Maymi M, Barrabés JA, Otaegui I, García Del Blanco B, Morr-Verenzuela CI, Lorenzatti D, Pérez-Solé N, Gavara J, Marcos-Garcés V, Ortiz-Pérez JT, Bodí V, Rodríguez-Palomares JF, Ferreira-González I.
Sex-based differences in adverse left ventricular remodelling and clinical outcomes after ST-segment elevation myocardial infarction.
Eur Heart J Cardiovasc Imaging. 2025 Apr 30;26(5):775-783
DOI: 10.1093/ehjci/jeaf048.
IF: 6.60

Belahnech Y, Ródenas-Alesina E, Muñoz MÁ, Verdu-Rotellar JM, Sao-Avilés A, Urio-Garmendia G, Osorio D, Salas K, Pantoja E, Ribera A, Ferreira-González I.
Systematic Coronary Risk Evaluation 2 for Older Persons: 10 years risk validation, clinical utility, and potential improvement.
Eur J Prev Cardiol. 2025 May 12;32(7):527-536.
DOI: 10.1093/eurjpc/zwae383
IF: 7.5

A human-centred and ethical development of digital and industrial technologies (DVPS: Diversis Viis, Plurima Solvis)
Principal Investigator: Andrea Guala
Agency: European Commission
Funding: 465,500 €
Period: 2025-2029

TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas. Fortalece
Principal Investigator: Begoña Benito
Agency: ISCIII
Funding: 416,288 €
Period: 2024-2027

Cardiovascular Toxicity in early Human Epidermal Growth Factor Receptor-2 -Positive Breast Cancer (HERBCA): From risk evaluation to prevention
Principal Investigator: Ignacio Ferreira
Agency: Marató TV3
Funding: 198,125 €
Period: 2024-2026

Degenerative ascending aortic aneurysms: Are dilation phenotypes related to etiology, pathophysiology, and prognosis?
Principal Investigator: J. Rodriguez Palomares
Agency: ISCIII
Funding: 200,000 €
Period: 2024-2026

Contribution of amino acid metabolism reprogramming and calpain deregulation to fibroblast activation and diffuse myocardial fibrosis in heart failure
Principal Investigator: Javier Inserte
Agency: ISCIII
Funding: 180,000 €
Period: 2024-2026

DEVICE AND METHOD FOR PHYSIOLOGY-GUIDED CARDIOPULMONARY RESUSCITATION
Priority Number: EP25382630.9
Priority Date: 20/06/2025
Applicants: VHIR 100%

Selective calpain-2 inhibitors for the treatment of myocardial hypertrophy Inventors
Priority Number: US 63/827,672
Priority Date: 07/09/2025
Applicants: NeurAegis

LAT1 SELECTIVE INHIBITORS FOR USE IN THE TREATMENT OF ADVERSE VENTRICULAR -REMODELLING AND OF HEART FAILURE
Priority Number: EP23383082.7
Priority Date: 30/04/2025
Applicants: VHIR 100%

7 press releases haves been published
Place: Online
Date: 2025
Brief: These news disseminate advances on different cardiovascular techniques and research.

Programme for the 2025 Cardiology Scientific Sessions
Place: Hospital Vall d'Hebron
Date: 2025
Brief: 18 sessions from January 2025 to June 2025 and 1 in November 2025. These sessions are training and updating in the fundamental advances in the different cardiology subspecialties at the pathophysiological, clinical and epidemiological levels to improve the competencies of professionals in the management of cardiovascular diseases and decision-making. These sessions are broadcasted live via a specific link, so they are not only for professionals who are present in person.

3 Conferences
Place: Hospital Vall d'Hebron and Hospital Univ. La Fe de Valencia
Date: 2025
Brief: 3 Conferences: 1) Jornada de Actualización en Tetralogía de Fallot 13- 14 June 2025 (Update on the management and treatment of patients with tetralogy of Fallot. 2) 37ª Jornada Actualización en imagen cardíaca 21-22 November 2025 (update on cardiac imaging in the treatment and management of cardiovascular diseases) 3) Jornada de Cardiopatías Familiares de la Comunidad Valenciana, el 26-09-25.

5 Updating Courses on various units of Cardiology
Place: Hospital Vall d'Hebron
Date: 2025
Brief: 1) Curso de Ecocardiografía en Cardiopatías Congénitas 12 June 2025 brief explanation: update in the ecocardiography and treatment of congenital heart diseases. 2) Curso teórico-práctico de ecocardiografía básica 16-17 September 2024 (Basic echocardiography theory and practice of transesophageal and transthoracic echocardiography). 3) Curso teórico-práctico avanzado en medicina de urgencias, intensiva y anestesia 29- September to October 2nd 2025 (Theory and practice of advanced cardiac imaging in emergency medicine, intensive care and anesthesia. 4) Curso 45º ecocardiografía, Doppler e Imagen multimodalidad 17 to 20 November 2025 (echocardiography, doppler and multimodality imaging used in different cardiovascular pathologies. 5) Curso de avances en estimulación cardíaca y sistemas implantables 1-2 December 2025 (advances in cardiac pacing and implantable systems)